Neurocrine Biosciences NBIX
NASDAQ NBIX
$174.41 +5.27 (+3.12%)
At close: Nov 11, 2026 · 4:00 PM EST

Neurocrine Biosciences (NBIX) Accounts Payables (2009 - 2026)

Updated

Analysis

Neurocrine Biosciences (NBIX) Accounts Payables (2009 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 5.79 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 9.32 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 34.43 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 5.03 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -23.57 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 2.95 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 934.00 Mn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 4.07 Bn
10 Neurocrine Biosciences 17.13 Bn 13.21 Bn 1.10 Bn 923.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 923.40 Mn
Jun 30, 2026 808.30 Mn
Mar 31, 2026 773.00 Mn
Dec 31, 2025 674.30 Mn
Sep 30, 2025 584.30 Mn
Jun 30, 2025 489.50 Mn
Mar 31, 2025 475.20 Mn
Dec 31, 2024 461.60 Mn
Sep 30, 2024 392.70 Mn
Jun 30, 2024 358.50 Mn
Mar 31, 2024 417.20 Mn
Dec 31, 2023 448.80 Mn
Sep 30, 2023 503.00 Mn
Jun 30, 2023 391.60 Mn
Mar 31, 2023 355.70 Mn
Dec 31, 2022 347.60 Mn
Sep 30, 2022 297.80 Mn
Jun 30, 2022 265.70 Mn
Mar 31, 2022 235.90 Mn
Dec 31, 2021 225.80 Mn
API Access

Neurocrine Biosciences Accounts Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accounts-payables&ticker=NBIX&period=max&api_key=YOUR_API_KEY